About Prosensa
Mission Statement
"" We aim to develop innovative, RNA-based therapeutics to fill unmet medical needs for patients with genetic diseases.""
Company Profile
Prosensa is a biopharmaceutical company focused on the discovery, development and commercialization of RNA modulating therapeutics. The company targets genetic disorders with a large unmet medical need, with a primary focus on neuromuscular disorders.
Strategy
Prosensa was established to develop novel treatments for life-threatening diseases based on its RNA modulation platform. Prosensa intends to discover, develop and commercialize these products and to create a specialized orphan drug franchise.
Strategic Partners
Prosensa closely collaborates with key academic centres, patient advocacy groups as well as corporate partners in order to achieve its objective of bringing innovative treatments to patients as quickly as possible.
Contact Prosensa
Phone: +31 (0) 71 33 22 100
Monday - Friday from 8.30 till 17.00